Uğur Şahin, BioNTech CEO (Andreas Arnold/picture-alliance/dpa/AP Images)
March 27, 2023 01:07 PM EDT
Pharma

BioN­Tech read­ies for plunge in Covid sales, will boost mR­NA and on­col­o­gy pipelines

Beth Snyder Bulik

Senior Editor

BioN­Tech is es­ti­mat­ing €5 bil­lion (near­ly $5.4 bil­lion) in Covid-19 vac­cine sales this year, a marked drop from €17.1 bil­lion ($18.5 bil­lion) in 2022 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times